Filter Results:
(4,661)
Show Results For
- All HBS Web
(4,661)
- People (16)
- News (1,868)
- Research (2,241)
- Events (2)
- Multimedia (220)
- Faculty Publications (1,827)
Show Results For
- All HBS Web
(4,661)
- People (16)
- News (1,868)
- Research (2,241)
- Events (2)
- Multimedia (220)
- Faculty Publications (1,827)
- 16 Jul 2010
- News
Health Insurance Rate Wars - Are We Focused on the Right Fight?
- 2021
- Working Paper
The Health Costs of Cost-Sharing
By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
We use the design of Medicare’s prescription drug benefit program to demonstrate three facts about the health consequences of cost-sharing. First, we show that an as-if-random increase of 33.6% in out-of-pocket price (11.0 percentage points (p.p.) change in... View Details
Chandra, Amitabh, Evan Flack, and Ziad Obermeyer. "The Health Costs of Cost-Sharing." NBER Working Paper Series, No. 28439, February 2021.
- March 2010 (Revised February 2014)
- Case
Community Health Workers in Zambia: Incentive Design and Management
By: Nava Ashraf and Natalie Kindred
This case examines the various considerations relevant to selecting and compensating workers in a context where their work involves a pro-social component. This is relevant to not only health care in Zambia, but to NGO and public sector workers who are both motivated... View Details
Keywords: Developing Countries and Economies; Training; Health Care and Treatment; Compensation and Benefits; Recruitment; Selection and Staffing; Mission and Purpose; Non-Governmental Organizations; Motivation and Incentives; Health Industry; Zambia
Ashraf, Nava, and Natalie Kindred. "Community Health Workers in Zambia: Incentive Design and Management." Harvard Business School Case 910-030, March 2010. (Revised February 2014.) (Request a courtesy copy.)
- January 2014 (Revised June 2014)
- Case
23andMe: Genetic Testing for Consumers (A)
By: John A. Quelch and Margaret L. Rodriguez
On November 22, 2013, the direct-to-consumer genetic testing provider, 23andMe, received a letter from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was... View Details
Keywords: Public Health; Genome Testing; Health Care; Ancestry; 23andMe; Marketing; Product Launch; Health; Health Care and Treatment; Health Testing and Trials; Genetics; Strategy; Health Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (A)." Harvard Business School Case 514-086, January 2014. (Revised June 2014.)
- Article
Assessing the Food and Drug Administration's Risk-Based Framework for Software Precertification with Top Health Apps in the United States: Quality Improvement Study
By: Noy Alon, Ariel Dora Stern and John Torous
BACKGROUND: As the development of mobile health apps continues to accelerate, the need to implement a framework that can standardize categorizing these apps to allow for efficient, yet robust regulation grows. However, regulators and researchers are faced with numerous... View Details
Keywords: Mobile Health; Smartphone; Food And Drug Administration; Risk-based Framework; Health Care and Treatment; Mobile and Wireless Technology; Applications and Software; Framework
Alon, Noy, Ariel Dora Stern, and John Torous. "Assessing the Food and Drug Administration's Risk-Based Framework for Software Precertification with Top Health Apps in the United States: Quality Improvement Study." JMIR mHealth and uHealth 8, no. 10 (October 2020).
- October 1999
- Article
Finding 'Truth' in Managed Care
Herzlinger, Regina E. "Finding 'Truth' in Managed Care." Journal of Health Politics, Policy and Law 24, no. 5 (October 1999).
- 17 Apr 2017
- News
HR’s New Challenge: Whole-Family Care
- November 2013 (Revised September 2015)
- Supplement
GlaxoSmithKline in China (B)
By: John A. Quelch and Margaret L. Rodriguez
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later,... View Details
Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (B)." Harvard Business School Supplement 514-050, November 2013. (Revised September 2015.)
- Teaching
Overview
By: Susanna Gallani
At HBS, Professor Gallani teaches in the Executive Education Program for Leadership Development and in focused Executive Education programs, including Managing Health Care Delivery, Driving Corporate Performance, and several programs focused on the implementation of... View Details
- October 2010 (Revised July 2011)
- Case
PrimedicProviding Primary Care in Mexico
By: Richard G. Hamermesh, Regina Garcia-Cuellar and Lauren Sarah Margulies
Primedic is a Mexican start-up that aims to deliver affordable primary and preventative healthcare to those at the base of the economic pyramid. The company is about to exhaust its first round of venture capital funding and the business model has yet to gain traction.... View Details
Keywords: Business Model; Business Startups; Developing Countries and Economies; Social Entrepreneurship; Venture Capital; Health Care and Treatment; Social Enterprise; Health Industry; Mexico
Hamermesh, Richard G., Regina Garcia-Cuellar, and Lauren Sarah Margulies. "PrimedicProviding Primary Care in Mexico." Harvard Business School Case 811-040, October 2010. (Revised July 2011.)
- 2009
- Working Paper
Mental Health in the Aftermath of Conflict
By: Quy-Toan Do and Lakshmi Iyer
We survey the recent literature on the mental health effects of conflict. We highlight the methodological challenges faced in this literature, which include the lack of validated mental health scales in a survey context, the difficulties in measuring individual... View Details
Keywords: Ethnicity; War; Health Disorders; Policy; Health Care and Treatment; Conflict and Resolution; Bosnia and Hercegovina
Do, Quy-Toan, and Lakshmi Iyer. "Mental Health in the Aftermath of Conflict." Harvard Business School Working Paper, No. 10-040, November 2009.
- September 2016
- Article
Value Based Care and Bundled Payments: Anesthesia Care Costs for Outpatient Oncology Surgery Using Time-driven Activity-based Costing
By: Katy E. French, Alexis B. Guzman, Augustin C. Rubio, John C. Frenzel and Thomas Feeley
Background:
With the movement towards bundled payments, stakeholders should know the true cost of the care they deliver. Time-driven activity-based costing (TDABC) can be used to estimate costs for each episode of care. In this analysis, TDABC is used to both... View Details
French, Katy E., Alexis B. Guzman, Augustin C. Rubio, John C. Frenzel, and Thomas Feeley. "Value Based Care and Bundled Payments: Anesthesia Care Costs for Outpatient Oncology Surgery Using Time-driven Activity-based Costing." Healthcare: The Journal of Delivery Science and Innovation 4, no. 3 (September 2016): 173–180.
- 09 Dec 2009
- Working Paper Summaries
Mental Health in the Aftermath of Conflict
Keywords: by Quy-Toan Do & Lakshmi Iyer
- October 2014 (Revised October 2014)
- Case
RedBrick Health: How to Fatten the Company That Slims...
By: Robert F. Higgins and Robert M. Greenglass
The case describes this health and wellness service company and poses the question: should RedBrick stay on the path of building out its product platform, or should the RedBrick platform be launched directly to health insurers, ACOs, or directly to customers? View Details
Keywords: ACOs; Accountable Care Organization; Healthcare; Health Services; Healthcare Industry; Health Engagement Company; Entrepreneurship; Health Care and Treatment; Growth and Development Strategy; Health Industry; United States
Higgins, Robert F., and Robert M. Greenglass. "RedBrick Health: How to Fatten the Company That Slims..." Harvard Business School Case 815-035, October 2014. (Revised October 2014.)
- October 2011 (Revised March 2012)
- Case
Cottle-Taylor: Expanding the Oral Care Group in India
By: John A. Quelch and Alisa Zalosh
Brinda Patel, director of oral care products for the India division of a consumer home-care product company, develops a data-driven marketing plan for toothbrushes. She believes her plan can support a 20% increase in unit sales based on rising demand for modern... View Details
Keywords: Forecasting; Budgeting; International Marketing; Product Planning & Policy; Sales Promotions; Marketing Plans; Products; Marketing Strategy; Consumer Behavior; Emerging Markets; Forecasting and Prediction; Advertising; Product Launch; Budgets and Budgeting; Product Development; Health Industry; Health Industry; India
Quelch, John A., and Alisa Zalosh. "Cottle-Taylor: Expanding the Oral Care Group in India." Harvard Business School Brief Case 114-350, October 2011. (Revised March 2012.)
- August 2001
- Case
Aurora Health Care: Finding "a Better Way"
By: Clayton M. Christensen and Kevin M. Dwyer
The largest hospital system in Wisconsin is trying to respond to new threats from nontraditional care providers. This case presents the hospital's dilemma as it tries to create change from within. View Details
Keywords: Change Management; Disruptive Innovation; Innovation Strategy; SWOT Analysis; Competitive Strategy; Health Industry
Christensen, Clayton M., and Kevin M. Dwyer. Aurora Health Care: Finding "a Better Way". Harvard Business School Case 602-043, August 2001.
- 11 Apr 2016
- News
Professor Raffaella Sadun on Improving Care in Hospitals
- January 2022
- Supplement
Somatus: Value-Based Kidney Care (B)
By: Ariel D. Stern, Robert S. Huckman and Sarah Mehta
Set in early 2020, this (B) case provides an update to the (A) case (no. 622-009) and provides additional context regarding the challenges facing Somatus. View Details
Keywords: Business Startups; Disruption; Entrepreneurship; Health; Health Care and Treatment; Health Disorders; Medical Specialties; Innovation and Invention; Disruptive Innovation; Management; Strategy; Business Strategy; Value; Value Creation; Health Industry; United States; Virginia
Stern, Ariel D., Robert S. Huckman, and Sarah Mehta. "Somatus: Value-Based Kidney Care (B)." Harvard Business School Supplement 622-045, January 2022.